Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Spotify Shares Surge 13 After AI Music Partnership with Universal Music Group and Upbeat Guidance UK Police Chiefs Push for Social Media Block for Under16s Regulatory Risks for Tech Firms Trump EPAs PFAS Destruction Plan Draws Industry and Health Concerns New York Fed Study Highlights Disproportionate Impact of Rising Gas Prices on LowerIncome Households Singapore Regulator Urges Banks to Accelerate Account Openings for Wealthy Clients Capri Holdings Q1 2026 Earnings EPS Beat Bolsters Investor Sentiment Despite Revenue Uncertainty YALA Q1 2026 Earnings EPS of 016 Drives 165 Stock Gain Despite Limited Data ENSG Q1 2026 Earnings Slight EPS Miss Amidst Steady Operations InMed Pharmaceuticals Q3 2025 Earnings Continued Losses as Stock Declines SSBI Q1 2026 Earnings EPS of 025 Reported Stock Gains Slightly Serina Therapeutics SER Faces Headwinds Shares Decline 3 Toward Support at 182 GE HealthCare GEHC Holds Steady Near Resistance as Volume Signals Caution WidePoint WYY Surges 856 as Volume Picks Up Key Levels to Watch DIAX Edges Lower as Options Overwrite Fund Navigates Support and Resistance Five Below Fabrinet Alamos Gold Among Analyst Favorites for Earnings Growth as Market Nears Highs Spotify Shares Gain on AIPowered Features and Service Expansion Novartis Raises FullYear Sales and Profit Guidance Signaling Strong Operational Momentum Steel Stocks Rally as Government Extends Minimum Import Price on 66 Steel Products Primoris Services Corporation PRIM Q1 2026 Earnings Profit Miss Overshadowed by Robust Stock Gains UVSP Q1 2026 Earnings Strong EPS Beat Amidst Modest Stock Movement ConnectOne Bancorp CNOBP Q1 2026 Earnings EPS Beats Estimates by 668 as Core Operations Show Resilience COCH Q1 2026 Earnings Narrower Loss Beats Estimates as Envoy Medical Advances Nasdaq Inc NDAQ Q1 2026 Earnings EPS Surpasses Estimates as Stock Ticks Higher CRVS Q1 2026 Earnings EPS Slightly Misses Estimates Amid Continued Clinical Development